NGOs Urge EU Ministers To Resist 'Industry Pressure' and Reform RnD Model, Raise Regulatory Standards
This article was originally published in SRA
Executive Summary
A group of 25 civil society bodies and NGOs have called on EU member states to resist what they describe as 'pressure from the pharmaceutical industry to eliminate critical elements of proposed EU Council Conclusions' that are intended to improve the balance between intellectual property measures designed to encourage innovation and the need to ensure patients have access to affordable medicines1.